Latest stock market news videos & Morning Bell

Interview Series

From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for both early-stage cancer diagnosis and treatment.

Weekly Wrap 3 July

Bell Direct

July 3, 2026

Weekly Wrap 19 June

Bell Direct

June 19, 2026

Weekly Wrap 12 June

Bell Direct

June 12, 2026

Market Wraps

Weekly Wrap 24 April

Bell Direct

April 24, 2026

Market Wraps

Weekly Wrap 17 April

Bell Direct

April 17, 2026

Market Wraps

Weekly Wrap 27 March

Bell Direct

March 27, 2026

Interview Series

From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.

Bell Direct

March 20, 2026

Interview Series

From the helm: Amplia (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct

March 20, 2026

Interview Series

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct

March 20, 2026

Interview Series

From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

Bell Direct

March 20, 2026

Interview Series

From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan

Bell Direct

March 20, 2026

Interview Series

From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu

Bell Direct

March 20, 2026